XTL Biopharmaceuticals (XTLB.US): Achieved $0 revenue in Q1 2024.
XTL Biopharmaceuticals(XTLB.US)：2024年Q1财报实现营收0美元。
XTL Biopharmaceuticals (XTLB.US): Achieved $0 revenue in Q1 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.